Tripla negatív emlőrák: vizsgálatok itt: Új-Zéland
3 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
- Where
- Crofton Downs, Newmarket
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06841354 · EU 2024-516834-36-00 - 3. fázisTaking peopleA Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- Where
- Auckland, Crofton Downs
- Életkor
- 18 év and over
- People
- 2400 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06966700 · EU 2024-520190-12-00 - Korai 1. fázisTaking peopleImaging Study in Metastatic UC, HR+ and HER2- Breast Cancer, TNBC, and NSCLC
- Where
- Christchurch
- Életkor
- 18 év and over
- People
- 40 worldwide
- Run by
- RayzeBio, Inc.
See details and how to joinNCT07671092